GlassScriptPhysician profile
Roy James Rindler
NPI 1235335712
$8,948.72
in general payments reported to CMS, 2019-2025
38 companies · $1,804 in 2025
The $1,804 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $676 · 2020: $672 · 2021: $997 · 2022: $1,400 · 2023: $1,471 · 2024: $1,929 · 2025: $1,804.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,188 · Education: $15.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,187.77 |
| Education | $15.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,163.00 | 2019-2025 | Skyrizi, Rinvoq |
| Novartis Pharmaceuticals Corporation | $1,111.00 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $961.40 | 2019-2025 | Dupixent, Libtayo |
| Lilly USA, LLC | $721.75 | 2019-2025 | Taltz, Olumiant, Ebglyss |
| Janssen Biotech, INC. | $696.28 | 2019-2025 | Tremfya |
| Pfizer INC. | $545.30 | 2019-2024 | |
| Leo Pharma INC. | $507.85 | 2020-2025 | Adbry |
| Genzyme Corporation | $462.10 | 2019-2025 | |
| Amgen INC. | $370.09 | 2020-2025 | Otezla |
| Organogenesis INC. | $363.81 | 2022-2025 | Cygnus Dual, Via Matrix, Simplimax |
| Sun Pharmaceutical Industries INC. | $302.13 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $270.31 | 2023-2025 | Sotyktu |
| Incyte Corporation | $216.16 | 2021-2025 | Opzelura |
| Mayne Pharma Commercial LLC | $135.33 | 2020-2025 | |
| Dermavant Sciences, INC. | $133.31 | 2023-2024 | Vtama |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roy Rindler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.